New York Blood Center Enterprises and Biohub Launch Collaboration to Advance Cord Blood–Derived Stem Cell Platforms

New York Blood Center Enterprises’ (NYBCe) Lindsley F. Kimball Research Institute (LFKRI) today announced a scientific ...

Verismo Therapeutics Presents Preclinical Data at AACR 2026 for SynKIR(TM)-310 KIR-CAR Indicating Superior Preclinical Activity in B Cell Malignancies and Early Clinical Efficacy

Preclinical data showed enhanced anti-tumor activity and reduced cytokine release compared to conventional single-chain CAR T approaches -- Early clinical case from CELESTIAL-301 trial, the ...
EurekAlert!

Advances in multi-omics for esophageal squamous cell carcinoma: Diagnostic, prognostic, and therapeutic perspectives

Esophageal squamous cell carcinoma (ESCC) is the predominant histological subtype of esophageal cancer, accounting for ...
Science Daily

Cell aging in one organ can snowball into multi-organ failure

The aging and failure of cells that occurs when one part of the body is damaged can spread to other organs, a study suggests. The ageing and failure of cells that occurs when one part of the body is ...
GEN

Multi-Sensor Monitoring of Cell Number and Viability

Cell number and viability matter from biological research to bioprocessing. So, scientists keep working on better ways to monitor these features of cell cultures. One promising approach comes from ...

Verismo Therapeutics Presents Preclinical Data at AACR 2026 for SynKIR™-310 KIR-CAR Indicating Superior Preclinical Activity in B Cell Malignancies and Early Clinical E…

Verismo Therapeutics, a clinical-stage CAR T cell therapy company pioneering a novel multi-chain KIR-CAR platform technology, ...